ARCHIVES

ASCO Guideline On Breast Cancer Risk Reduction Updated

This article is from The Cancer Letter archive.

Vol. 35 No. 21 | May 29, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Scientists May Run For Congress; Upton Back Heroin For Terminal Cancer Patients

September 9, 1977

Clinical Trials Approved By NCI

November 28, 2003

Micafungin Bests Fluconazole In Phase III Antifungal Trial

November 29, 2002

DCT Advisors Reject MRS Concept, Approve RDOG Expansion

November 30, 1990

Radiation Therapy Combination Better For Treating Cancer Spread To Brain

May 28, 2004

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001